Cargando…
多发性骨髓瘤患者应用达雷妥尤单抗120 min快速输注方案的安全性和可行性
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520231/ https://www.ncbi.nlm.nih.gov/pubmed/37803849 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.08.017 |
| _version_ | 1785109871204499456 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10520231 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105202312023-09-27 多发性骨髓瘤患者应用达雷妥尤单抗120 min快速输注方案的安全性和可行性 Zhonghua Xue Ye Xue Za Zhi 经验交流 Editorial office of Chinese Journal of Hematology 2023-08 /pmc/articles/PMC10520231/ /pubmed/37803849 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.08.017 Text en 2023年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License. |
| spellingShingle | 经验交流 多发性骨髓瘤患者应用达雷妥尤单抗120 min快速输注方案的安全性和可行性 |
| title | 多发性骨髓瘤患者应用达雷妥尤单抗120 min快速输注方案的安全性和可行性 |
| title_full | 多发性骨髓瘤患者应用达雷妥尤单抗120 min快速输注方案的安全性和可行性 |
| title_fullStr | 多发性骨髓瘤患者应用达雷妥尤单抗120 min快速输注方案的安全性和可行性 |
| title_full_unstemmed | 多发性骨髓瘤患者应用达雷妥尤单抗120 min快速输注方案的安全性和可行性 |
| title_short | 多发性骨髓瘤患者应用达雷妥尤单抗120 min快速输注方案的安全性和可行性 |
| title_sort | 多发性骨髓瘤患者应用达雷妥尤单抗120 min快速输注方案的安全性和可行性 |
| topic | 经验交流 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520231/ https://www.ncbi.nlm.nih.gov/pubmed/37803849 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.08.017 |
| work_keys_str_mv | AT duōfāxìnggǔsuǐliúhuànzhěyīngyòngdáléituǒyóudānkàng120minkuàisùshūzhùfāngàndeānquánxìnghékěxíngxìng AT duōfāxìnggǔsuǐliúhuànzhěyīngyòngdáléituǒyóudānkàng120minkuàisùshūzhùfāngàndeānquánxìnghékěxíngxìng AT duōfāxìnggǔsuǐliúhuànzhěyīngyòngdáléituǒyóudānkàng120minkuàisùshūzhùfāngàndeānquánxìnghékěxíngxìng AT duōfāxìnggǔsuǐliúhuànzhěyīngyòngdáléituǒyóudānkàng120minkuàisùshūzhùfāngàndeānquánxìnghékěxíngxìng AT duōfāxìnggǔsuǐliúhuànzhěyīngyòngdáléituǒyóudānkàng120minkuàisùshūzhùfāngàndeānquánxìnghékěxíngxìng AT duōfāxìnggǔsuǐliúhuànzhěyīngyòngdáléituǒyóudānkàng120minkuàisùshūzhùfāngàndeānquánxìnghékěxíngxìng AT duōfāxìnggǔsuǐliúhuànzhěyīngyòngdáléituǒyóudānkàng120minkuàisùshūzhùfāngàndeānquánxìnghékěxíngxìng AT duōfāxìnggǔsuǐliúhuànzhěyīngyòngdáléituǒyóudānkàng120minkuàisùshūzhùfāngàndeānquánxìnghékěxíngxìng AT duōfāxìnggǔsuǐliúhuànzhěyīngyòngdáléituǒyóudānkàng120minkuàisùshūzhùfāngàndeānquánxìnghékěxíngxìng AT duōfāxìnggǔsuǐliúhuànzhěyīngyòngdáléituǒyóudānkàng120minkuàisùshūzhùfāngàndeānquánxìnghékěxíngxìng AT duōfāxìnggǔsuǐliúhuànzhěyīngyòngdáléituǒyóudānkàng120minkuàisùshūzhùfāngàndeānquánxìnghékěxíngxìng AT duōfāxìnggǔsuǐliúhuànzhěyīngyòngdáléituǒyóudānkàng120minkuàisùshūzhùfāngàndeānquánxìnghékěxíngxìng |